Skip to main content
. 2022 Aug 27;14(8):754–764. doi: 10.4240/wjgs.v14.i8.754

Table 3.

Postoperative pathological results for patients in two cohorts


OGC (n = 48)
3DLAGC (n = 36)
P value
Pathological type, n (%) 0.521
Well differentiated 24 (50.0) 21 (58.3)
Moderately differentiated 19 (39.6) 10 (27.8)
Poorly differentiated (including signet-ring cell carcinoma) 5 (10.4) 5 (13.9)
Tumor size (mm) 38.67 (30.51) 35.22 (30.93) 0.612
TNM, n (%) 0.084
18 (37.5) 15 (41.7)
Ⅱa 11 (22.9) 8 (22.2)
Ⅱb 9 (18.8) 1 (2.8)
Ⅲa 4 (8.3) 9 (25.0)
Ⅲb 4 (8.3) 3 (8.3)
Ⅲc 2 (4.2) 0 (0.0)
Depth of tumor invasion, n (%) 0.826
T1 10 (20.8) 9 (25.0)
T2 9 (18.8) 7 (19.4)
T3 17 (35.4) 13 (36.1)
T4 10 (25.0) 5 (19.5)
Lymph nodes metastases, n (%) 0.205
N0 34 (70.8) 20 (55.6)
N1 6 (12.5) 8 (22.2)
N2 2 (4.2) 5 (13.9)
N3 6 (12.5) 3 (8.3)
Number of positive lymph nodes (n) 2.35 (5.28) 1.56 (2.84) 0.413
Total number of lymph nodes retrieved (n) 10.73 (6.82) 14.00 (7.17) 0.036

All continuous variables were described by mean ± SD; Enumeration data were presented by percentage (%). OGC: Open gastrectomy for carcinoma in the remnant stomach; 3DLAGC: 3D laparoscopic assisted gastrectomy for carcinoma in the remnant stomach; TNM: Pathological staging (pTNM) according to American Joint Committee on Cancer (AJCC) TNM Staging Classification for Carcinoma of the Stomach (8th ed).